PACB

Pacific Biosciences Of California
$1.36
$0.00 (0%)Jul 27, 2026
2.8FairMoatMint rating

MoatMint rates Pacific Biosciences Of California (PACB) 2.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.1 out of 10.

Key metrics

The numbers that frame PACB today
Market cap
$422.42M
P/E (TTM)
-3.3
EV / FCF
-16.2
Gross margin
37.5%
EV / Sales
6.7
ROIC
-11.6%
Div yield
0%
Debt / equity
297.3
52wk Low
$1.09
52wk High
$2.73

PACB stock rating

How PACB scores on quality, value, growth, momentum and financial health
2.8out of 10
Fair overallFair business, expensive priceTop 72% of ~5,000 US stocks
QualityFair3.1/10
GrowthGreat9.8/10
MomentumFair3.4/10
ValueFair2.4/10
Financial HealthFair2.0/10

Growth

Revenue and earnings trend for PACB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about PACB
Is Pacific Biosciences Of California a good buy?
No. Pacific Biosciences Of California has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Pacific Biosciences Of California is selling at a very high price.
What is the market capitalization of PACB?
Pacific Biosciences Of California's market capitalization is $422.42M.
What is the P/E ratio for PACB stock?
Pacific Biosciences Of California's current P/E ratio is -3.3.
What is the 52-week high for PACB stock?
The 52-week high for Pacific Biosciences Of California is $2.73. The current close of $1.36 is 50.2% below that high.
What is the 52-week low for PACB stock?
The 52-week low for Pacific Biosciences Of California is $1.09. The current close of $1.36 is 24.8% above that low.
Does PACB stock pay dividends?
Pacific Biosciences Of California does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PACB?
Pacific Biosciences Of California's Debt / Equity ratio is 297.29.